GenSight Biologics 주식 가격. SIGHT - 주식 시세, 차트, 과거 거래, 주식 채팅, 재무.

다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

홈
인베스팅
주식
유럽
EU
GenSight Biologics S.A. (SIGHT) 시세

GenSight Biologics S.A. (SIGHT)

0.31

-0.0025

( -0.80% )

업데이트: 21:05:02

개인 투자자를 위한 전문가급 도구.

가격

0.31

매수가

0.309

매도가

0.314

거래량

116,514

0.305 일간 변동폭 0.321

0.28 52주 범위 0.598

market_cap

전일 종가

0.3125

개장가

0.3145

최근 거래 시간

마지막 거래 시간

20:45:09

재정 규모

-

VWAP

-

평균 볼륨(3m)

341,917

발행 주식

78,370,724

배당수익률

-

주가수익률

-0.96

주당순이익(EPS)

-0.33

매출

2.96M

순이익

-26.22M

섹터

Biological Pds,ex Diagnstics

산업

Biological Pds,ex Diagnstics

웹사이트

www.gensight-biologics.com

본부

Paris, Paris, Fra

설립됨

-

GenSight Biologics S.A. is listed in the Biological Pds,ex Diagnstics sector of the 유로넥스트 (Euronext) with ticker SIGHT. The last closing price for GenSight Biologics was 0.31 €. Over the last year, GenSight Biologics shares have traded in a share price range of 0.28 € to 0.598 €.

GenSight Biologics currently has 78,370,724 shares in issue. The market capitalisation of GenSight Biologics is 24.49 € million. GenSight Biologics has a price to earnings ratio (PE ratio) of -0.96.

GenSight Biologics announces a financing for an amount of c. €2.8 million from existing investors

Regulatory News: This press release is not being made in and copies of It may not be distributed or sent, directly or indirectly, into the United States, Canada, South Africa, Japan or...

GENSIGHT BIOLOGICS : Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

Article 223-16 du règlement Général de l’AMF Regulatory News : GENSIGHT BIOLOGICS (Paris:SIGHT) : (Code ISIN : FR0013183985) Date Nombre d’actions composant le capital Nombre de droits de vote...

GenSight Biologics : Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

Article 223-16 du règlement Général de l’AMF Regulatory News: GenSight Biologics (Paris:SIGHT) (Code ISIN : FR0013183985): Date Nombre d’actions composant le capital Nombre de droits de vote...

GENSIGHT BIOLOGICS : Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

Article 223-16 du règlement Général de l’AMF Regulatory News: GENSIGHT BIOLOGICS (Paris:SIGHT): Date Nombre d’actions composant le capital Nombre de droits de vote brut1 Nombre de droits de...

GENSIGHT BIOLOGICS: Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

Article 223-16 du règlement Général de l’AMF Regulatory News: GENSIGHT BIOLOGICS (Paris:SIGHT): (Code ISIN : FR0013183985) Date Nombre d’actions composant le capital Nombre de droits de vote...

GENSIGHT BIOLOGICS : Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

Article 223-16 du règlement Général de l’AMF Regulatory News: GENSIGHT BIOLOGICS (Paris:SIGHT) (Code ISIN : FR0013183985) Date Nombre d’actions composant le capital Nombre de droits de vote...

GENSIGHT BIOLOGICS : Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

Article 223-16 du règlement Général de l’AMF Regulatory News: GENSIGHT BIOLOGICS (Paris:SIGHT) (Code ISIN : FR0013183985) Date Nombre d’actions composant le capital Nombre de droits de vote...

GENSIGHT BIOLOGICS : Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

Article 223-16 du règlement Général de l’AMF Regulatory News: GENSIGHT BIOLOGICS (Paris:SIGHT) (Code ISIN : FR0013183985) Date Nombre d’actions composant le capital Nombre de droits de vote...

GENSIGHT BIOLOGICS : Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

Article 223-16 du règlement Général de l’AMF Regulatory News: GENSIGHT BIOLOGICS (Paris:SIGHT) (Code ISIN : FR0013183985) Date Nombre d’actions composant le capital Nombre de droits de vote...

GENSIGHT BIOLOGICS : Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

Article 223-16 du règlement Général de l’AMF Regulatory News: GENSIGHT BIOLOGICS (Paris:SIGHT) (Code ISIN : FR0013183985) Date Nombre d’actions composant le capital Nombre de droits de vote...

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	-0.039	-11.1747851003	0.349	0.349	0.305	225503	0.32539824	DE
4	0.029	10.3202846975	0.281	0.369	0.28	264303	0.31544825	DE
12	-0.105	-25.3012048193	0.415	0.448	0.28	341917	0.357469	DE
26	-0.083	-21.1195928753	0.393	0.496	0.28	276453	0.36517291	DE
52	-0.166	-34.8739495798	0.476	0.598	0.28	201512	0.38897991	DE
156	-5.75	-94.8844884488	6.06	6.135	0.28	203683	1.52406887	DE
260	-0.848	-73.2297063903	1.158	9.69	0.28	295321	3.24922838	DE

가장 활성
% 상승자
% 패자

기호	가격	볼륨
BIDSGascogne DS	0.0054 € (200.00%)	63.85k
ALCYBCybergun	0.0002 € (100.00%)	3.52M
ALNEVNeovacs	0.0003 € (50.00%)	43M
ALMASMastrad	0.0114 € (32.56%)	5.23M
ALCBICrypto Blockchain Industries	0.28 € (21.74%)	668.97k
EBUSEbusco Holding NV	0.9199 € (-24.97%)	2.14M
FINMFinanciere Marjos	0.076 € (-20.83%)	110
MLCMGCMG Clean Tech	1.00 € (-17.36%)	1.76k
VACBSPierre & Vacances	0.048 € (-14.29%)	427
ALMUNMunic S.A.	0.576 € (-12.99%)	6.64k
ALNEVNeovacs	0.0003 € (50.00%)	43M
ATODSAtos SE	0.0048 € (17.07%)	18.29M
ALTDTonner Drones	0.0098 € (6.52%)	12.62M
BCPBanco Comercial Portugues SA	0.4423 € (0.57%)	11.97M
ALVERVergnet	0.0045 € (-6.25%)	10.38M

Mark954

Mark954 2 분 전

Phoenix Group's senior leadership, two of them are on the board of directors for TechCom TCRI. The Phoenix Group is the beneficial/majority owner of the TCRI shell. Do we see a dual listing situation coming to this shell company? They are most definitely going to want to get at the U.S capital mark

Hulk Hogan is God

Hulk Hogan is God 2 분 전

style="caret-color: rgb(34, 34, 34); color: rgba(34, 34, 34, 1); font-family: "Noto Serif", "Fallback for Noto Serif", "Times New Roman", serif; background-color: rgba(249, 249, 249, 1)""The company reported a gross profit of $235,000 for the quarter, compared to $2,177,000 in the previous year, wit

trunkmonk

trunkmonk 2 분 전

https://finance.yahoo.com/news/apollo-ceo-marc-rowan-tapped-062052745.html
No matter who, Mnuchin didnt disclose a lot of his investment from what i remember

silkcash

silkcash 2 분 전

Monksdream

Monksdream 3 분 전

TRNR
https://ih.advfn.com/markets/nasdaq/premarket

chevelle 396

chevelle 396 3 분 전

WTF how is this moving south on this news !!!!

chevelle 396

chevelle 396 3 분 전

WTF how is this moving south on this news !!!!

KVM

OK guess back to restructuring mode. Cause presentation said 500 +. Again no one knows what the hell is going on there as they sit at home on their couches pretending to work.

Lurker3

Lurker3 4 분 전

Why do you feel bad for kcc. Is it because they hold kcc on a leash with their dinners, leaked messages, phone calls?

Or is it because they were using him as a puppet?

I dont want to be in kcc shoes knowing that he was being played for an entire year.

misterfishman

misterfishman 5 분 전

True and makes sense maybe there are issues with the RM we don't know about that would explain the delay with the name change.

WooptdooU

WooptdooU 6 분 전

Did OLED stop without GRIFTER lebby? No, it thrived...CORPORATE WELFARIST, GRIFTER lebby needs to go. Let's see if the pic industry likes a guy like him after all...

WebSlinger

WebSlinger 6 분 전

>

That is a completely false narrative.

The last time, SMCI didn't report financials for about a year (between Nov 2017 and Aug 2018) and they had received 7 Notices of Delisting before they

misterfishman

misterfishman 7 분 전

I say forget about this one and come back in a year go trade other plays while this one grows ,if one keep watching this everyday then the impatience and frustration will only drive one nuts.

blanka

blanka 8 분 전

lol you been saying that since $30k

JOoa0ky

JOoa0ky 9 분 전

They'd have to sell all their shares prior to accepting the position.
Hence why John Paulson -declined-

eagpup

eagpup 10 분 전

I hope nexboard does have great success? However, I have heard these great stories of the next best things that will disrupt and be successful. I am at the prove it to me stage. I would like to be part of a penny stock that beats the odds. But the reality is, few penny stocks make it. Put up or I am

Iggy_Bot

Iggy_Bot 10 분 전

Just a “Elderly Man with a Poor Memory”

PonkenPlonken

PonkenPlonken 11 분 전

Does anyone in here believe SAVA is a scam? Ph3 results coming soon and they already went above and beyond to cheat on the ph1 and ph2 data set. The ph3 data set will be impossible to skew I believe.

GBR

In yesterdays Needham conference,

RS said they had 485 employees

misterfishman

misterfishman 11 분 전

Of course. Rome conquered and robbed everybody at the time.

Truth_is_a_tool

Truth_is_a_tool 11 분 전

Or not lol . Oh well. Maybe next week 🤷‍♂️

Thomas@yahoo

Thomas@yahoo 13 분 전

Welcome Back and Now Our 47th PRESIDENT OF THE UNITED STATES DONALD J. TRUMP
https://www.marijuanamoment.net/dr-oz-could-elevate-medical-marijuana-support-as-trumps-medicare-and-medicaid-director/

https://www.marijuanamoment.net/fda-approves-long-awaited-clinical-trial-of-smoke

IB_

As we both know "nasrat said" is not even close to a guarantee !!!!!!!!!!!

I only go by what "nasrat did" .....

How many ANDA's has "nasrat said" would be filed in 2024 ???????????

How many were actually filed ???????????

Hey Thanks A Lot

GBR

Well my take on that is much of the underlying tech with aiWARE is from AWS.

I think aiWARE is basically a patented framework. Using open source tech and AWS tech, but applying it to their own proprietary patented framework or AI operating system as they call it.

Eve

GenSight Biologics

Dicks Sporting Goods

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관